BC
AMGN icon

Bridgefront Capital’s Amgen AMGN Stock Holding History

Bridgefront Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,228
Closed -$2.9M – 504
2026
Q1 		$2.9M Buy
+8,228
New +$2.93M 0.72% 12
2025
Q3 		– Sell
-1,575
Closed -$440K – 573
2025
Q2 		$440K Buy
+1,575
New +$446K 0.12% 306
2025
Q1 		– Sell
-5,929
Closed -$1.55M – 605
2024
Q4 		$1.55M Buy
5,929
+3,103
+110% +$921K 0.52% 22
2024
Q3 		$911K Buy
+2,826
New +$924K 0.35% 62
2023
Q1 		– Sell
-1,982
Closed -$521K – 411
2022
Q4 		$521K Buy
+1,982
New +$531K 0.36% 88
2021
Q3 		– Sell
-3,200
Closed -$780K – 319
2021
Q2 		$780K Buy
+3,200
New +$787K 0.29% 79
2021
Q1 		– Sell
-3,300
Closed -$759K – 656
2020
Q4 		$759K Buy
+3,300
New +$761K 0.26% 109

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bridgefront Capital's AMGN Position: Q2 2026 in Review

Bridgefront Capital sold out of Amgen (AMGN) in Q2 2026, closing a stake of 8,228 shares — an estimated $2.9M sold.

Bridgefront Capital first reported a position in AMGN in Q4 2020 and held it in 7 quarters. The position peaked at $2.9M in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bridgefront Capital reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 8,228 Amgen shares in Q2 2026, an estimated $2.9M.
  • Bridgefront Capital first reported a position in Amgen in Q4 2020 and held it in 7 quarters.
  • Bridgefront Capital's Amgen position peaked at $2.9M in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.